Xylem Laboratory System Enables Online Monitoring and Control of Bioreactors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Xylem Laboratory System Enables Online Monitoring and Control of Bioreactors

Equipment and Processing Report

Xylem's 2900M Online Monitoring and Control System includes an online sampler, analyzer, and controller for laboratory bioreactors. The YSI Sitini Online Sampler from Xylem can be set up to automatically draw fluids from

the bioreactor, delivering samples directly to the 2900 biochemistry analyzer for testing. Sampling is done aseptically with no risk of contamination, as lines are flushed and antiseptic is kept in them after each drawing.

The analyzer measures glucose, glutamine, glutamate, lactate, and other analytes, with accurate results in less than one minute. The components of the 2900M system are autoclavable. The analyzer and the Sitini Sampler can also connect to process management instruments via RS232, ethernet, or OPen Connectivity (OPC) to incorporate into existing applications, and the searchable database allows for quick access to stored results.

Source: Xylem Analytics

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Equipment and Processing Report,
Click here